Verastem Valuation
| VSTM Stock | USD 3.57 0.61 20.61% |
At this time, the company appears to be undervalued. Verastem has a current Real Value of $9.71 per share. The regular price of the company is $3.57. Our model measures the value of Verastem from inspecting the company fundamentals such as Shares Owned By Insiders of 0.91 %, current valuation of 98.77 M, and Return On Equity of -1.1 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Verastem's valuation include:
Price Book 6.3191 | Enterprise Value 98.8 M | Enterprise Value Ebitda (0.19) | Price Sales 11.9121 | Enterprise Value Revenue 9.8773 |
Undervalued
Today
Please note that Verastem's price fluctuation is slightly risky at this time. Calculation of the real value of Verastem is based on 3 months time horizon. Increasing Verastem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Verastem stock is determined by what a typical buyer is willing to pay for full or partial control of Verastem. Since Verastem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Verastem Stock. However, Verastem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.57 | Real 9.71 | Target 30.5 | Hype 2.95 | Naive 2.91 |
The intrinsic value of Verastem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Verastem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Verastem helps investors to forecast how Verastem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Verastem more accurately as focusing exclusively on Verastem's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Verastem's intrinsic value based on its ongoing forecasts of Verastem's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Verastem's closest peers.
Verastem Cash |
|
Verastem Valuation Trend
Knowing Verastem's actual value is paramount for traders when making sound investment determinations. Using both Verastem's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Verastem Total Value Analysis
Verastem is at this time anticipated to have valuation of 98.77 M with market capitalization of 119.12 M, debt of 41.56 M, and cash on hands of 94.31 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Verastem fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
98.77 M | 119.12 M | 41.56 M | 94.31 M |
Verastem Asset Utilization
One of the ways to look at asset utilization of Verastem is to check how much profit was generated for every dollar of assets it reports. Verastem has a negative utilization of assets of -0.42 %, losing $0.004151 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Verastem shows how discouraging it operates for each dollar spent on its assets.Verastem Ownership Allocation
Verastem shows a total of 40.24 Million outstanding shares. 30% of Verastem outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Verastem Profitability Analysis
Net Loss for the year was (87.37 M) with profit before overhead, payroll, taxes, and interest of 2.6 M.About Verastem Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Verastem. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Verastem based exclusively on its fundamental and basic technical indicators. By analyzing Verastem's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Verastem's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Verastem. We calculate exposure to Verastem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Verastem's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -62 K | -58.9 K | |
| Pretax Profit Margin | (32.70) | (34.33) | |
| Operating Profit Margin | (32.31) | (30.69) | |
| Net Loss | (32.71) | (34.35) | |
| Gross Profit Margin | 1.10 | 0.95 |
Verastem Growth Indicators
Investing in growth stocks can be very risky. If the company such as Verastem does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 22.1 M |
Verastem Current Valuation Indicators
Verastem's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Verastem's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Verastem, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Verastem's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Verastem's worth.When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.21) | Revenue Per Share 0.372 | Quarterly Revenue Growth (1.00) | Return On Assets (0.42) | Return On Equity (1.10) |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.